C1181
Carboxyethyl-γ-aminobutyric acid
≥80% (HPLC)
Synonym(s):
CEGABA
Sign Into View Organizational & Contract Pricing
Select a Size
About This Item
Empirical Formula (Hill Notation):
C7H13NO4
CAS Number:
Molecular Weight:
175.18
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:
Assay
≥80% (HPLC)
SMILES string
OC(=O)CCCNCCC(O)=O
InChI
1S/C7H13NO4/c9-6(10)2-1-4-8-5-3-7(11)12/h8H,1-5H2,(H,9,10)(H,11,12)
InChI key
SRGQUICKDUQCKO-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Biochem/physiol Actions
Cell growth promoter
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
F Fussi et al.
Neuroscience letters, 77(3), 308-310 (1987-06-26)
The di-carboxylated derivative of spermidine, N-carboxyethyl gamma-aminobutyric acid (CEGABA) has been identified in bovine brain and human cerebrospinal fluid by HPLC. This discovery strongly suggests the existence of a metabolic pathway connecting polyamines and GABA via putreanine and CEGABA through
A Cerino et al.
Biochemical and biophysical research communications, 150(3), 931-936 (1988-02-15)
A polyamine derivative, carboxyethyl - Aminobutyric Acid (CEGABA), induces the formation of a large number of Epstein-Barr Virus (EBV) transformed lymphocytes, when added to the culture medium immediately after EBV infection. However, CEGABA shows only a moderate effect on the
Vani Dos Santos Laranjeira et al.
Archives of dermatological research, 311(6), 491-497 (2019-05-16)
Cosmeceuticals are cosmetics formulated using compounds with medical-like benefits. Though the antiaging effect of carboxyethyl aminobutyric acid (CEGABA) has been discussed, its action mechanism in cosmeceuticals remains unclear. This study assessed the in vitro efficacy and safety of CEGABA. NHI-3T3
Pharmacological effects of CEGABA, a new aminoacid occurring in mammalian brain.
F Savoldi et al.
Il Farmaco; edizione scientifica, 42(1), 77-79 (1987-01-01)
P Bo et al.
Il Farmaco; edizione scientifica, 43(4), 363-372 (1988-04-01)
The central effects of carboxyethyl-gamma-aminobutyric acid (CEGABA) have been studied both in rabbits and in the guinea pig myoclonus model. This drug caused EEG synchronization and behavioural sedation both after intravenous (i.v.) and intracerebroventricular (i.c.v.) administration in a dose-dependent manner
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service